Jacek Skarbinski, M.D., from Oakland Medical Center in California, and colleagues assessed COVID-19 vaccine effectiveness (VE) and the number needed-to-vaccinate (NNV) among people with cancer. The ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

New research has revealed factors associated with an increased risk of COVID-19-related death and hospitalization among patients with cancer.

In a first-of-its-kind clinical trial, UCLA scientists have shown it's possible to reprogram a patient's blood-forming stem ...